Susquehanna International Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
186,015
+31,661
| +21% | +$301K | ﹤0.01% | 2435 |
|
|
2025
Q1 | $1.61M | Buy |
154,354
+74,840
| +94% | +$783K | ﹤0.01% | 2589 |
|
|
2024
Q4 | $1.87M | Buy |
79,514
+46,645
| +142% | +$1.1M | ﹤0.01% | 2074 |
|
|
2024
Q3 | $1.18M | Buy |
32,869
+7,348
| +29% | +$264K | ﹤0.01% | 2461 |
|
|
2024
Q2 | $901K | Sell |
25,521
-415,013
| -94% | -$14.6M | ﹤0.01% | 2704 |
|
|
2024
Q1 | $12.5M | Buy |
440,534
+414,516
| +1,593% | +$11.8M | ﹤0.01% | 539 |
|
|
2023
Q4 | $346K | Sell |
26,018
-48,030
| -65% | -$639K | ﹤0.01% | 4361 |
|
|
2023
Q3 | $663K | Buy |
74,048
+53,041
| +252% | +$475K | ﹤0.01% | 3046 |
|
|
2023
Q2 | $236K | Sell |
21,007
-29,506
| -58% | -$332K | ﹤0.01% | 4477 |
|
|
2023
Q1 | $582K | Buy |
50,513
+33,489
| +197% | +$386K | ﹤0.01% | 3621 |
|
|
2022
Q4 | $197K | Sell |
17,024
-9,627
| -36% | -$112K | ﹤0.01% | 4504 |
|
|
2022
Q3 | $338K | Buy |
+26,651
| New | +$338K | ﹤0.01% | 4074 |
|
|
2021
Q2 | – | Sell |
-14,682
| Closed | -$228K | – | 5449 |
|
|
2021
Q1 | $228K | Buy |
+14,682
| New | +$228K | ﹤0.01% | 4648 |
|